Bidirectional heterologous desensitization of opioid and chemokine receptors

Annals of the New York Academy of Sciences

Volumn 917, Issue , 2000, Pages 19-28

  Rogers, T J ^a,b   Steele, A D ^a   Howard, O M Z ^b   Oppenheim, J J ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; INTERLEUKIN 1; INTERLEUKIN 6; MU OPIATE RECEPTOR AGONIST; OPIATE RECEPTOR; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY PRODUCTION; CELL POPULATION; CHEMOTAXIS; CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; DESENSITIZATION; IMMUNE RESPONSE; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTOSIS; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0033670372     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05369.x     Document Type: Conference Paper

References (51)

1. Infections resulting from narcotic addiction
2. The major medical complications of heroin addiction
3. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients
4. Immune status of unselected methadone maintained former heroin addicts
5. Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers
6. Alteration of T and null lymphocyte frequencies in the peripheral blood of hyman opiate addicts: In vivo evidence for opiate receptor sites on T lymphocytes
7. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression
8. Drug dependence, a possible new risk factor for tuberculosis disease
9. Serious infections other than human immunodeficiency virus among intravenous drug users
10. Regulation of the in vitro antibody response by neuroendocrine hormones
11. Immunomodulatory activity of μ- and κ-selective opioid agonists
12. Differential effects of morphine and naltrexone on the antibody response in various mouse strains
13. Suppression of the induction of delayed hypersensitivity in rats by repetitive morphine treatments
14. Suppressive effects of morphine pellet implants on in vivo parameters of immune function
15. Chronic morphine administration impairs cell-mediated immune responses in swine
16. The periaqueductal gray matter mediates opiate-induced immunosuppression
17. Stress neuropeptides, immunity and neoplasia
18. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism
19. Effect of morphine on resistance to infection
20. Methadone vs. morphine: Comparison of their effect on phagocytic functions
21. Augmenting effect of opioid peptides on murine macrophage activation
22. Met-enkephalin induced alterations of macrophage functions
23. Bidirectional effect of met-enkephalin on macrophage effector functions
24. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages
25. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids
26. Opioid peptides modulate production of interferon-gamma by human mononuclear cells
27. Opioid-mediated suppression of interferon-γ production by cultured peripheral blood mononuclear cells
28. β-Endorphin modulation of IL-1-induced IL-2 production
29. + T cells
30. β-Endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis
31. Opiate receptor-mediated chemotaxis of human monocytes
32. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis
33. Opiates transdeactivate chemokine receptors: Delta and mu opiate-receptor mediated heterologous desensitization
34. Opioids depress in vitro human monocyte chemotaxis
35. Effects of in vivo and in vitro administration of morphine sulfate upon Rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis
36. Identification of RANTES receptors on human monocytic cells: Competition for binding and desensitization by homologous desensitization by homologous chemotactic cytokines
37. Opiate inhibition of chemokine-induced chemotaxis
38. Delta opioid receptor gene expression in lymphocytes
39. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation
40. Multistep navigation and the combinatorial control of leukocyte chemotaxis
41. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration
42. G-protein-coupled receptors: Turn-ons and turn-offs
43. G protein-coupled receptor kinase 2 (GRK2): Mechanisms of regulation and physiological function
44. Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity
45. Molecular mechanisms of desensitization of the chemokine receptor CCR-5: Receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor
46. 2 binding site distinguishes the GRK subfamilies
47. Protein kinase cross-talk: Membrane targeting of the β-adrenergic receptor kinase by protein kinase C
48. Phosphorylation and activation of β-adrenergic receptor kinase by protein kinase C
49. 2+/calmodulin
50. Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C
51. Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain